
Cipla (CIPLA) Share Price falls 2.32% as Healthcare peers stay mixed
Updated: 8 Oct 2026 • 12:59 pm
Posted by:

Cipla Share Price was at Rs 1,298.60, down 2.32% from the previous close, with market capitalisation at Rs 1,08,497.02 crore. The decline matters because Cipla Share Price moved below Rs 1,300 during the ongoing session, bringing the day’s price action and valuation context into focus. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. Cipla Share Price therefore has to be read through the lens of what is verified today: the intraday range, the session-to-session change, the company’s Large Cap tag, and the Healthcare backdrop. Cipla Share Price is also relevant for investors tracking Cipla Stock News, Cipla Share Price Today and Cipla Share Price Live, because the move comes without a stated news trigger in the visible data.
For readers following Cipla Share Price on Univest, the key point is simple: the stock is trading lower in the latest session, while the company still carries a substantial market cap and a set of fundamentals that sit within the broader Pharmaceuticals & Drugs universe. That makes Cipla Share Price a stock analysis question, not just a one-line price update.
Cipla (CIPLA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,298.6 |
| Previous Close | Rs 1,329.5 |
| Today's Move | -Rs 30.90 (-2.32%) |
| Open | Rs 1,311.05 |
| High | Rs 1,333.9 |
| Low | Rs 1,298.05 |
| Market Capitalisation | Rs 1,08,497.02 crore |
| Market Cap Category | Large Cap |
Cipla Share Price today opened at Rs 1,311.05, touched a high of Rs 1,333.90 and a low of Rs 1,298.05, before last trading at Rs 1,298.60. The move from the previous close of Rs 1,329.50 to the latest level reflects a decline of Rs 30.90, or 2.32%. Cipla Share Price therefore traded near the lower end of the day’s range, with the session’s lowest trade sitting just below the current price. The company is classified as a Large Cap, and its market capitalisation of Rs 1,08,497.02 crore keeps Cipla Share Price in the upper tier of listed Healthcare names.
This price action is important because Cipla Share Price Today combines a clear fall with a narrow gap between the day’s low and the latest traded price, while the day’s high remains well above the current level. Cipla Share Price News headlines will likely focus on the drop, but the verified numbers themselves only establish the move, not the reason. For that reason, Cipla Share Price should be followed together with fundamentals and sector comparison rather than treated as a standalone move. Cipla Share Price and Cipla Share Price Update both point to the same intraday picture, which leads naturally into the company’s financial context.
Cipla (CIPLA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,08,497.02 crore |
| P/E Ratio | 31.87x |
| P/B Ratio | 3.06x |
| ROE | 11.83% |
| ROCE | 16% |
| EPS | Rs 41.72 |
| Book Value Per Share | Rs 435.18 |
| Dividend Yield | 0.98% |
Cipla (CIPLA) fundamental metrics show P/E 31.87x, P/B 3.06x, ROE 11.83%, ROCE 16%. These figures provide context only and are not a buy or sell signal.
Cipla has a market capitalisation of Rs 1,08,497.02 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.87x, P/B at 3.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.83% and ROCE of 16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 41.72, book value per share of Rs 435.18, dividend yield of 0.98%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.87x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 3.06x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 11.83% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 16% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 1,08,497.02 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Cipla (CIPLA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Cipla (CIPLA) has a P/E ratio of 31.87x, which is equal to the benchmark median of 31.87x, a difference of 0%. On its own, the P/E gap is a valuation reference point, not a trading call.
Cipla (CIPLA) has a ROE of 11.83%, which is above the benchmark median of 11.61%, a difference of +1.89%. Cipla (CIPLA) has a ROCE of 16%, which is above the benchmark median of 13.46%, a difference of +18.87%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Cipla (CIPLA) has a P/E ratio of 31.87x compared with the displayed peer median of 82.14x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 11.83% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 16% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Cipla (CIPLA) has a market capitalisation of Rs 1,08,497.02 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Cipla
- Cipla Share Price fell 2.32% to Rs 1,298.60, making the latest session the main price event to watch.
- Cipla Share Price trades near the lower end of the day’s range, after opening at Rs 1,311.05 and touching Rs 1,298.05.
- Cipla Share Price has a P/E of 31.87 and a P/B of 3.06, so valuation remains an active part of the discussion.
- Cipla Share Price shows ROE of 11.83% and ROCE of 16.00%, which help frame the fundamental view.
- Cipla Share Price sits in a Large Cap Healthcare company with a market cap of Rs 1,08,497.02 crore and a broad peer set.
About Cipla
Cipla operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Cipla Share Price reflects a company that is part of a large and established listed pharmaceutical universe. The business is known for drug development, manufacturing and distribution across healthcare categories, and its market position is assessed against several major Indian peers. Cipla Share Price therefore belongs to a sector where valuation, returns and company scale matter together. For investors following Cipla Share Price, the company description is inseparable from its role as a Large Cap pharmaceutical name with a significant market capitalisation and industry-wide comparison set.
Track Cipla Share Price on Univest
Use Cipla (CIPLA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Track Cipla Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. Cipla Share Price can be followed alongside peer comparison, sector context and stock analysis tools that help you read the latest move with verified data. Univest also keeps Cipla Share Price connected to broader company context, so investors can review the stock without losing sight of valuation and industry placement.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Cipla Share Price falling today?
Ans. Cipla Share Price fell 2.32% to Rs 1,298.60 from the previous close of Rs 1,329.50. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Cipla Share Price today?
Ans. Cipla Share Price was Rs 1,298.60 at the latest update. The stock opened at Rs 1,311.05, touched Rs 1,333.90, and saw a low of Rs 1,298.05 during the session. The previous close was Rs 1,329.5.
How much did Cipla Share Price decline?
Ans. Cipla Share Price declined by Rs 30.90, which equals 2.32%. The move was measured against the previous close of Rs 1,329.50 and keeps the day’s change firmly in negative territory.
What is the market cap of Cipla?
Ans. Cipla has a market capitalisation of Rs 1,08,497.02 crore. That places Cipla Share Price in the Large Cap category and well above the benchmark median within the same industry universe.
What is Cipla Share Price valuation on P/E and P/B?
Ans. Cipla Share Price carries a P/E ratio of 31.87 and a P/B ratio of 3.06. The P/E matches the industry median, while the P/B is slightly above the benchmark median of 2.98.
How do ROE and ROCE look for Cipla Share Price?
Ans. Cipla Share Price shows ROE of 11.83% and ROCE of 16.00%. Both sit above the industry benchmark medians, which helps add context to the stock’s valuation in the Healthcare sector.
What do EPS, book value and dividend yield show for Cipla?
Ans. Cipla Share Price has EPS of Rs 41.72, book value of Rs 435.18 per share and dividend yield of 0.98%. These figures help frame earnings, accounting value and payout context for investors.
How does Cipla compare with Healthcare peers?
Ans. Cipla Share Price sits in the middle of its peer group on P/E. It is below Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals, while its ROCE is stronger than several peers but below Lupin and Divi’s.
Should investors track Cipla Share Price on Univest?
Ans. Yes, investors can track Cipla Share Price on Univest for live updates, fundamental ratios, 52-week levels and sector context. It is useful for following the stock’s movement alongside verified valuation and peer data.
Recent Articles

Parsvnath Developers Ltd. Hits Lower Circuit on BSE, 17 November 2026
17 November 2026

Vedant Poly Fabs Ltd. Hits Lower Circuit on NSE, 17 November 2026
17 November 2026

Trident Techlabs Ltd. Hits Lower Circuit on NSE, 17 November 2026
17 November 2026

MOBILISE APP LAB LIMITED Hits Lower Circuit on NSE, 17 November 2026
17 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Parsvnath Developers Ltd. Hits Lower Circuit on BSE, 17 November 2026
Vedant Poly Fabs Ltd. Hits Lower Circuit on NSE, 17 November 2026
Trident Techlabs Ltd. Hits Lower Circuit on NSE, 17 November 2026
MOBILISE APP LAB LIMITED Hits Lower Circuit on NSE, 17 November 2026
Anand Rayons Ltd. Hits Lower Circuit on BSE, 17 November 2026
Popular this week
Kemp & Company Ltd. Hits Lower Circuit on BSE, 17 November 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





